New cancer drug begins human testing

This was an early-stage study to test the safety and find the right dose of a new drug called BAT1308 for people with advanced solid tumors that had stopped responding to standard treatments. The study involved 59 participants with cancers like non-small cell lung cancer, liver cancer, and cervical cancer. Researchers first tested increasing doses to check for side effects, then expanded the study to see how the drug behaved in the body and if it showed any early signs of fighting the cancer.